Zomedica Pharmaceuticals (AMEX:ZOM) reported quarterly sales of $6.20 million which met the analyst consensus estimate. This is a 51.92 percent increase over sales of $4.08 million the same period last year.
What Does Lands’ End’s Debt Look Like?
Shares of Lands' End Inc. (NASDAQ:LE) moved lower by 12.54% in the past three months. Before having a look at the importance of debt, let's look at how much debt Lands' End has.
